COCA:一个随机的贝叶斯设计,集成剂量优化和组件贡献评估,用于组合疗法
Xiaohan Chi1, Ruitao Lin1, Ying Yuan1
1Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.
Biometrics
|June 24, 2025
概括
这项研究引入了一种针对癌症组合疗法的新型两阶段临床试验设计. 它有效地优化药物剂量并评估个体药物贡献,显著减少样本大小要求.
科学领域:
- 在瘤学瘤学.
- 临床试验设计 临床试验设计
- 生物统计学 生物统计学
背景情况:
- 开发有效的癌症组合疗法需要优化药物剂量并了解每个成分的贡献.
- 传统方法在早期阶段的试验中需要大量的样本,这给药物开发人员带来了挑战.
研究的目的:
- 为综合组合剂量优化和组件贡献评估提出一种新的两阶段随机化第二阶段设计.
- 通过适应性数据组合来提高试验效率和减少样本大小.
主要方法:
- 一个两阶段的随机二期设计,整合剂量优化和贡献评估.
- 第1阶段:根据风险与益处的权衡选择最佳组合剂量.
- 第二阶段:多臂随机化评估组件贡献,与适应贝叶斯逻辑回归 (spike-and-slab前) 进行数据聚合.
主要成果:
- 拟议的设计成功实现了剂量优化和成分贡献评估的双重目标.
- 与现有设计相比,广泛的模拟表明了与现有设计相比,实质性样本大小的节省.
- 一种新的校准程序确保了对样本大小和决策截止值的期望操作特征.
结论:
- 拟议的适应性两阶段设计为开发癌症组合疗法提供了一种有效的方法.
- 这种方法解决了优化剂量和评估药物贡献的关键需求,同时尽量减少样本大小.
- 该设计为加速药物开发和改善组合治疗的风险效益概况提供了有价值的工具.
相关概念视频
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Dose-Response Relationship: Overview
3.8K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.8K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
184
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
184
Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Dose-Response Relationship: Potency and Efficacy
5.3K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
5.3K
Crossover Experiments
3.7K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
3.7K


